Filing Details

Accession Number:
0001127602-23-001064
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-01-06 16:04:24
Reporting Period:
2023-01-04
Accepted Time:
2023-01-06 16:04:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1145197 Insulet Corp PODD Surgical & Medical Instruments & Apparatus (3841) 043523891
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1631895 Shacey Petrovic C/O Insulet Corporation
100 Nagog Park
Acton MA 01720
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-01-04 10,445 $46.22 25,234 No 4 M Direct
Common Stock Acquisiton 2023-01-04 4,555 $74.50 29,789 No 4 M Direct
Common Stock Disposition 2023-01-04 15,000 $281.88 14,789 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2023-01-04 10,445 $0.00 10,445 $46.22
Common Stock Employee Stock Option (Right to Buy) Disposition 2023-01-04 4,555 $0.00 4,555 $74.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2027-02-22 No 4 M Direct
11,838 2028-02-14 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 73,205 Indirect By NG Trust
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to an existing Rule 10b5-1 trading plan.
  2. The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $278.63 to $289.70. Specifically: 3,144 shares were sold in the range of $278.63 to $279.62, with a weighted average share price of $279.20; 2,556 shares were sold in the range of $279.65 to $280.59, with a weighted average share price of $280.05; 2,337 shares were sold in the range of $280.66 to $281.39, with a weighted average share price of $281.13; 2,775 shares were sold in the range of $281.67 to $282.55, with a weighted average share price of $282.17;
  3. Footnote continued:898 shares were sold in the range of $282.73 to $283.68, with a weighted average share price of $283.33; 1,184 shares were sold in the range of $283.78 to $284.53, with a weighted average share price of $284.06; 700 shares were sold in the range of $284.82 to $285.18, with a weighted average share price of $284.89; 800 shares were sold in the range of $286.44 to $286.79, with a weighted average share price of $286.66; 300 shares were sold in the range of $287.68 to $288.45, with a weighted average share price of $288.10; 306 shares were sold in the range of $289.25 to $289.70, with a weighted average share price of $289.38. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
  4. This option is subject to a four-year vesting period with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment.